Boston Partners, a renowned financial services business, purchased a position in Constellium SE (NYSE:CSTM). Boston Partners bought 47,044 shares of the industrial goods company’s stock for $557,000. Boston Partners continues to invest in industrial products with this move.
Constellium SE is a global leader in aluminum-based solutions for automotive, aerospace, and packaging. The company’s eco-friendly, high-quality goods service some of the world’s most esteemed companies.
Constellium SE missed analysts’ consensus earnings per share projections in its April 26th quarterly results announcement, while leading its industry. EPS was $0.15, compared to $0.27, with a net margin of 1.74%. Despite this setback, equities research analysts predict 1.33 EPS for Constellium this year.
Market volatility and industrial product demand might make investing in Constellium SE risky. However, hedge funds like Boston Partners have showed trust in Constellium SE by purchasing shares.
Constellium investors may receive real-time hedge fund and insider trading alerts
In conclusion, Boston Partner’s acquisition of Constellium SE shares shows investor interest and opportunities in the industrial goods industry notwithstanding individual company issues.
Large investors invested more in Constellium SE, a prominent aluminium products maker. Highland Capital Management LLC invested $122,000 in Constellium in the fourth quarter of 2020, while Envestnet Asset Management Inc. increased its holdings by 93.2% to 42,479 shares worth $503,000.
Highland Peak Capital LLC bought a $6,614,000 investment, Symmetry Investments LP bought $1,517,000, and ProShare Advisors LLC added 16.7%. Institutional investors control 92.86% of the company’s equity, causing suspicion.
CSTM began Wednesday at $15.10 with a market valuation of $2.18 billion, a PE ratio of 15.41, and a beta of 1.88. The firm has historically made aeronautical and packaging aluminum products. I
n February 2020, BMO Capital Markets raised their target price on Constellium from $15 to $20 and gave a “outperform” rating, while Credit Suisse Group retained their “outperform” rating and forecasted a $22 target price.